Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 1/2010

01.03.2010 | Original Research

A Study Comparing Endoscopic Ultrasound (EUS) and Computed Tomography (CT) in Staging Oesophageal Cancer and their Role in Clinical Decision Making

verfasst von: Duminda Subasinghe, Dharmabandhu Nandadeva Samarasekera

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Background and Aim

Computed tomography (CT) and endoscopic ultrasound (EUS) are part of the regular preoperative staging protocol in oesophageal cancer. At present, EUS is increasingly being used for preoperative locoregional staging of oesophageal cancer. The aim of this study is to compare EUS and CT findings and their role in clinical decision making.

Methods

The CT staging of 30 patients with oesophageal carcinoma was compared with EUS. This is a single centre-based study, and the EUS was carried out by a single operator.

Results

The mean age was 58.2 years. On EUS, one (3.3%), five (16.7%), 16(53.3%) and eight (26.7%) patients had T1, T2, T3 and T4 tumours, respectively, compared with CT which showed 12(40%), nine (30%) and seven (23.3%) patients with T2, T3 and T4 tumours. On CT, two (6.7%) were shown as no tumour (T0). EUS revealed lymph node involvement in 25 (83.3%) patients compared with CT which indicated lymph node involvement in seven (23.3%) patients. On EUS, coeliac node involvement was shown in four (13.3%) patients (M1). The TNM staging of CT and EUS were comparable in nine (30%) patients. EUS staging revealed a more advanced stage of oesophageal cancer in 17 (56.7%) patients. Preoperative EUS staging changed the decision of management in 15 (50%) patients (P < 0.005).

Conclusions

EUS staging revealed a more advanced stage of cancer in the majority of patients. It appears to be far more superior in detecting lymph node involvement compared with CT. Therefore, EUS may have a significant impact on deciding the treatment modality of a patient with oesophageal carcinoma.
Literatur
1.
Zurück zum Zitat Day NE, Varghese C. Oesophageal cancer. Cancer Surv. 1994;19–20:43–54.PubMed Day NE, Varghese C. Oesophageal cancer. Cancer Surv. 1994;19–20:43–54.PubMed
2.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.CrossRefPubMed Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.CrossRefPubMed
3.
Zurück zum Zitat Chang-Claude JC, Wahrendorf J, Liang QS, Rei YG, Muñoz N, Crespi M, et al. An epidemiological study of precursor lesions of esophageal cancer among young persons in a high risk population in Huixian, China. Cancer Res. 1990;50(8):2268–74.PubMed Chang-Claude JC, Wahrendorf J, Liang QS, Rei YG, Muñoz N, Crespi M, et al. An epidemiological study of precursor lesions of esophageal cancer among young persons in a high risk population in Huixian, China. Cancer Res. 1990;50(8):2268–74.PubMed
4.
Zurück zum Zitat Muller J, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical treatment of oesophageal carcinoma. Br J Surg. 1990;77:845–57.CrossRefPubMed Muller J, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical treatment of oesophageal carcinoma. Br J Surg. 1990;77:845–57.CrossRefPubMed
5.
Zurück zum Zitat Siewert J, Dittler H. Oesophageal cancer: impact of staging on treatment. Endoscopy. 1993;25:28–32.CrossRefPubMed Siewert J, Dittler H. Oesophageal cancer: impact of staging on treatment. Endoscopy. 1993;25:28–32.CrossRefPubMed
6.
Zurück zum Zitat Chandawarkar RY, Kakegawa T, Fujita H, Yamana H, Hayabuthi N. Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer. J Surg Oncol. 1996;61(3):214–7.CrossRefPubMed Chandawarkar RY, Kakegawa T, Fujita H, Yamana H, Hayabuthi N. Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer. J Surg Oncol. 1996;61(3):214–7.CrossRefPubMed
7.
Zurück zum Zitat Ziegler K, Sanft C, Zeitz M, et al. Evaluation of endosonography in TN staging of oesophageal cancer. Gut. 1991;32:16–20.CrossRefPubMed Ziegler K, Sanft C, Zeitz M, et al. Evaluation of endosonography in TN staging of oesophageal cancer. Gut. 1991;32:16–20.CrossRefPubMed
8.
Zurück zum Zitat Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991;181:419–25.PubMed Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991;181:419–25.PubMed
9.
Zurück zum Zitat Tio TL, Coene PPLO, Schouwink MH, Tytgat GNJ. Esophagogastric carcinoma: preoperative TNM classification with endosonography. Radiology. 1989;173:411–7.PubMed Tio TL, Coene PPLO, Schouwink MH, Tytgat GNJ. Esophagogastric carcinoma: preoperative TNM classification with endosonography. Radiology. 1989;173:411–7.PubMed
10.
Zurück zum Zitat Tadashi Nishimaki, Otsuo Tanaka, Nobutoshi Ando, et al. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg. 1999;68:2059–64.CrossRef Tadashi Nishimaki, Otsuo Tanaka, Nobutoshi Ando, et al. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg. 1999;68:2059–64.CrossRef
11.
Zurück zum Zitat Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–6.PubMed Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–6.PubMed
12.
Zurück zum Zitat American Joint committee on cancer. TNM Classification and stage grouping of oesophageal carcinoma. In: Greene FL, Page DL, Fleming ID, et al, eds. Cancer staging manual. 6th Edition. New York: Springer; 2002. p. 91–98. American Joint committee on cancer. TNM Classification and stage grouping of oesophageal carcinoma. In: Greene FL, Page DL, Fleming ID, et al, eds. Cancer staging manual. 6th Edition. New York: Springer; 2002. p. 91–98.
13.
Zurück zum Zitat Nishimaki T. An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between western and eastern standards. Ann Thorac Cardiovasc Surg. 2006;12(4):231–3.PubMed Nishimaki T. An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between western and eastern standards. Ann Thorac Cardiovasc Surg. 2006;12(4):231–3.PubMed
14.
Zurück zum Zitat Mackay S, Stefanou G. Management of esophageal carcinoma. Aust Fam Physician. 2006;35(4):202–6.PubMed Mackay S, Stefanou G. Management of esophageal carcinoma. Aust Fam Physician. 2006;35(4):202–6.PubMed
15.
Zurück zum Zitat Shah JN, Ahamad NA, Beilstein MC, et al. Clinical impact of endoscopic ultrasonography on the management of malignancies. Clin Gastroenterol Hepatol. 2004;2:1069–73.CrossRefPubMed Shah JN, Ahamad NA, Beilstein MC, et al. Clinical impact of endoscopic ultrasonography on the management of malignancies. Clin Gastroenterol Hepatol. 2004;2:1069–73.CrossRefPubMed
16.
Zurück zum Zitat Pfau PR, Ginsberg GG, Lew RJ, et al. EUS predictors of long term survival in oesophageal carcinoma. Gastrointest Endosc. 2001;53:463–9.CrossRefPubMed Pfau PR, Ginsberg GG, Lew RJ, et al. EUS predictors of long term survival in oesophageal carcinoma. Gastrointest Endosc. 2001;53:463–9.CrossRefPubMed
17.
Zurück zum Zitat Shumarker DA, de Garmo P, Faigel DO. Potential impact of pre operative EUS on oesophageal cancer management and cost. Gastrointest Endosc. 2002;56:391–3.CrossRef Shumarker DA, de Garmo P, Faigel DO. Potential impact of pre operative EUS on oesophageal cancer management and cost. Gastrointest Endosc. 2002;56:391–3.CrossRef
18.
Zurück zum Zitat Nick NJ, Bhutani MS, et al. Clinical impact of endoscopic ultrasound: the American endosonography club study. Gastrointest Endosc. 1996;44:371–7.CrossRef Nick NJ, Bhutani MS, et al. Clinical impact of endoscopic ultrasound: the American endosonography club study. Gastrointest Endosc. 1996;44:371–7.CrossRef
19.
Zurück zum Zitat Gheorghe C, Stanescu C, Gheorghe L, Bancila I, Herlea V, Becheanu G, et al. Preoperative noninvasive EUS evaluation in patients with esophageal cancer considered for esophagectomy. J Gastrointestin Liver Dis. 2006;2:137–41. Gheorghe C, Stanescu C, Gheorghe L, Bancila I, Herlea V, Becheanu G, et al. Preoperative noninvasive EUS evaluation in patients with esophageal cancer considered for esophagectomy. J Gastrointestin Liver Dis. 2006;2:137–41.
20.
Zurück zum Zitat Shimpi RA, George J, Jowell P, Gress FG. Staging of esophageal cancer by EUS: staging accuracy revisited. Gastrointest Endosc. 2007;66(3):475–82.CrossRefPubMed Shimpi RA, George J, Jowell P, Gress FG. Staging of esophageal cancer by EUS: staging accuracy revisited. Gastrointest Endosc. 2007;66(3):475–82.CrossRefPubMed
21.
Zurück zum Zitat Morris JM, Suzuki H, McKernan M, Stephen M, Stuart RC, Stanley AJ. Impact of EUS-FNA in the management of patients with oesophageal cancer. Scott Med J. 2009;54(2):30–3.PubMed Morris JM, Suzuki H, McKernan M, Stephen M, Stuart RC, Stanley AJ. Impact of EUS-FNA in the management of patients with oesophageal cancer. Scott Med J. 2009;54(2):30–3.PubMed
22.
Zurück zum Zitat Kutup A, Link BC, Schurr PG, Strate T, Kaifi JT, Bubenheim M, et al. Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy. 2007;39(8):715–9.CrossRefPubMed Kutup A, Link BC, Schurr PG, Strate T, Kaifi JT, Bubenheim M, et al. Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy. 2007;39(8):715–9.CrossRefPubMed
23.
Zurück zum Zitat Akiyama H, Tsurumara M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the oesophagus. Ann Surg. 1981;194:438–46.CrossRefPubMed Akiyama H, Tsurumara M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the oesophagus. Ann Surg. 1981;194:438–46.CrossRefPubMed
24.
Zurück zum Zitat Igaki H, Kato H, Tachimori Y, Nakanishi Y, Shimoda T. Surgery for T3 carcinomas of the upper thoracic esophagus and the need for new strategies. Br J Surg. 2005;92:1235–40.CrossRefPubMed Igaki H, Kato H, Tachimori Y, Nakanishi Y, Shimoda T. Surgery for T3 carcinomas of the upper thoracic esophagus and the need for new strategies. Br J Surg. 2005;92:1235–40.CrossRefPubMed
25.
Zurück zum Zitat Forshaw MJ, Gossage JA, Chrystal K, Cheong K, Atkinson S, Botha A, et al. Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction. Eur J Surg Oncol. 2006;32(10):1114–8.CrossRefPubMed Forshaw MJ, Gossage JA, Chrystal K, Cheong K, Atkinson S, Botha A, et al. Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction. Eur J Surg Oncol. 2006;32(10):1114–8.CrossRefPubMed
Metadaten
Titel
A Study Comparing Endoscopic Ultrasound (EUS) and Computed Tomography (CT) in Staging Oesophageal Cancer and their Role in Clinical Decision Making
verfasst von
Duminda Subasinghe
Dharmabandhu Nandadeva Samarasekera
Publikationsdatum
01.03.2010
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 1/2010
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-009-9105-8

Weitere Artikel der Ausgabe 1/2010

Journal of Gastrointestinal Cancer 1/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.